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Purpose 
Previous studies suggest that the non-
adherence rate is between 25-30% 
depending on the treatment type. Some 
of the leading causes of non-adherence 
were fear of side effects and a lack of 
confidence in the treatment plan’s 
effectiveness. Studies have not 
evaluated the impact that pharmacists 
have in improving adherence to diabetes 
management. 
This study aimed to assess 
compliance with and obstacles to 
medication treatment plan adherence 
in patients with Type 2 Diabetes, as 
well as determine possible steps 
pharmacists can take to increase rates.  
Medication adherence is the measure of 
faithfulness to a treatment plan as 
prescribed by a physician. Patient 
adherence to medication administration 
is critical to obtaining desired results. 
Assessing compliance rates and 
obstacles that patients face can help 
pharmacists understand how to promote 
higher adherence. Understanding these 
obstacles is crucial because consistent 
failure to adhere to Diabetes Type 2 
treatment can result in serious health 
problems such as nerve damage, 
blindness, and skin ulcerations.  
An electronic survey was created, 
using the website Qualtrics, to assess 
the adherence tendencies of 
respondents with Type 2 Diabetes. The 
survey was sent by email to the faculty, 
staff, and students of Cedarville 
University, but only those who are 
currently using medication to treat 
Type 2 Diabetes were asked to 
participate. Twenty-eight responses 
were received and the data was 
analyzed using Qualtrics and Excel.   
 
This study showed that 75% of 
respondents did not completely adhere 
to their treatment program. Some 
reasons for non-adherence determined 
were pain or discomfort, not 
remembering doses, taking multiple 
medications and losing track, difficulty 
in reading prescription labels or 
instructions, difficulty obtaining refills, 
low confidence in effectiveness of 
treatment plan, fear of side effects, and 
Based on this study, the leading factors 
in non-adherence were forgetfulness, 
busyness, and cost. Pharmacists who 
wish to combat the high non-adherence 
rate in those with Type 2 Diabetes 
should devise methods to help patients 
overcome these obstacles. 
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preference for non-medical treatment. 
The most common reasons for 
noncompliance were forgetfulness, 
busyness, and cost of medication. 
Results showed that neither gender nor 
age had a significant impact on 
adherence rate.  
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Common Reasons for Non-Adherence  
